Current Issue - Pharmaceutical Executive

ADVERTISEMENT

Current Issue

The Avian Few: Is it Too Late for Pharma to Re-enter the Vaccine Fray?

December 1, 2005

Like the course of a pandemic itself, the great avian influenza scare came in waves. In 1997, the first case of the now infamous H5N1 strain of bird flu emerged in Hong Kong, infecting 18 people and killing six. In late 2003 it struck again—more than 120 people fell ill and at least 60 died over the next two years. Then this fall, David Nabarro, MD, the UN coordinator for avian and human influenza, shocked everyone when he said a bird flu pandemic could claim up to 150 million lives—a figure the World Health Organization (WHO) quickly retracted.

Direct to Consumer: Culturally Relevant Marketing

December 1, 2005

By immersing themselves in the culture of the target audience—visiting where they live, shop, and consume media—marketers can discover what consumers want and need before they demand it.

Inside DDMAC: A Conversation with Thomas Abrams

December 1, 2005

Despite heightened scrutiny from industry advocates and the beginnings of self-imposed regulation, pharma companies' violations of DTC regulations have been getting worse, says Tom Abrams, director of FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC). Abrams has been on all sides of drug marketing, from receiving promotions as a pharmacist to creating promotions as a member of industry to regulating promotions as the head of DDMAC. As such, he's in good position to see the big picture.

How Much Do You Really Know About Pharma: The Answers to PharmExec's December 2005 Quiz

December 1, 2005

Find out how you did on our December 2005 quiz.

Bustin' a CAP: The Competative Acquisition Program

November 1, 2005

Medicare's Competitive Acquisition Program takes a shot at reforming Part B drug distribution. But the new rules evoke a vast and complicated Rube Goldberg machine, where nobody gains much—except CMS.

Marketing to Professionals: Detailing

November 1, 2005

While the typical brand invests more than $100 million in annual sales force support, it spends on average less than $2 million to determine whether the detail piece is driving prescriptions.

From the Editor: Lost World

November 1, 2005

Leo H. Sternbach's death feels like the end of an era, a time when the new drugs came easily and it was possible to have a huge impact on patients, then turn around and do it again.

Meetings: Incorporating Technology

November 1, 2005

It's time to raise the ante and start using technology to create the kind of high-energy, interactive, information-rich environment young Americans crave:a 21st century environment for learning.

Legal: State Compulsory Licenses

November 1, 2005

Under one bill, states could license patented drugs to generics companies, paying patent holders a royalty.

ADVERTISEMENT

Click here